MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence Protection Status
Blog Category: 

By Industry News

Toronto, CANADA – June 11, 2020 – MolecuLight Inc., the creator of a point-of-care fluorescence imaging device for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has assigned an Ambulatory Payment Classification (APC) code 5722 for the MolecuLight i:X imaging procedure for point-of-care real-time fluorescence wound imaging for bacterial presence, location and load (CPT® code 0598T (Category III)). The new APC code is effective July 1, 2020 and enables facility reimbursement under the Medicare Hospital Outpatient Prospective Payment System (OPPS), with a 2020 hospital outpatient payment rate of approximately $253.10 USD. This is in addition to the two category III CPT codes (0598T and 0599T), which also become active on July 1, 2020, that enable physicians to request payment from payers for their work providing the MolecuLight i:X imaging procedure.

"It is an important reimbursement milestone for MolecuLight that CMS, the largest payer for health care in the US, has reviewed the large body of supporting evidence and recognized the medical necessity of the MolecuLight procedure and therefore granted an APC assignment," says Anil Amlani, MolecuLight’s CEO. "MolecuLight is dedicated to advancing the quality of clinical information provided to physicians at the time it is most needed to immediately improve patients' treatments and outcomes." The MolecuLight i:X is the world's first and only portable imaging device that provides information about bacteria causing infection at the point-of-care, allowing physicians to chart their course to heal wounds. Bacteria in wounds causes healing delays of weeks to months and results in costly patient visits and procedures. There are over 6 million procedures provided to wound care patients annually in the US.

"Implementing the use of the MolecuLight i:X at Northwell has transformed our wound assessment and bacterial management practices," says Dr. Alisha Oropallo, Director of the Comprehensive Wound Healing and Hyperbaric Center, Northwell Health, Lake Success, NY. "The device provides essential diagnostic information at the point-of-care on the presence of bacteria in wounds that has dramatically improved our treatment planning and patient care. This information is vital to our wound clinicians for assessing, triaging, and monitoring wound patients and I see this technology as the future standard of care for wound treatment."

The new CPT procedure codes (0598T and 0599T) may be applied when using the MolecuLight i:X to identify bacteria in wounds at loads greater than 104 colony forming units (CFU) per gram. While coding and assignment to an APC enables reimbursement, each payer must decide on coverage based on the medical necessity of the patient encounter.

*NOTE: CPT is a registered trademark of the American Medical Association.

About MolecuLight Inc.
MolecuLight Inc. ( is a privately owned Canadian medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical and commercial markets. MolecuLight’s initial product, the MolecuLight i:X®, and its accessories delivers a real-time handheld fluorescence imaging solution for the global wound care market. The MolecuLight i:X provides clinicians with information about the fluorescent characteristics of wounds to assist clinicians in making improved diagnostic and treatment decisions. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.

Related company: 

Recommended for You

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.